Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 4

1(25.0%)

Phase 3

1(25.0%)

4Total

N/A(2)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT04362085Phase 3Completed

Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care

Role: collaborator

NCT05368792Not ApplicableUnknown

Prospective Trial Of Osmolar Protocol Solution on Colonoscopy Outcomes and Patient Experience

Role: lead

NCT03174067Phase 4Completed

Buprenorphine in the Emergency Department

Role: lead

NCT00813930Not ApplicableUnknown

Lifestyle Intervention For Effective Diabetes Management

Role: collaborator

All 4 trials loaded